222 related articles for article (PubMed ID: 25298284)
1. Identification of differentially methylated genes in the malignant transformation of ovarian endometriosis.
Ren F; Wang DB; Li T; Chen YH; Li Y
J Ovarian Res; 2014 Jul; 7():73. PubMed ID: 25298284
[TBL] [Abstract][Full Text] [Related]
2. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
Ren F; Wang DB; Li T
Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of hMLH1 in the malignant transformation of ovarian endometriosis.
Ren F; Wang D; Jiang Y; Ren F
Arch Gynecol Obstet; 2012 Jan; 285(1):215-21. PubMed ID: 21556900
[TBL] [Abstract][Full Text] [Related]
4. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis.
Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P
Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219
[TBL] [Abstract][Full Text] [Related]
5. Oestrogen up-regulates DNMT1 and leads to the hypermethylation of RUNX3 in the malignant transformation of ovarian endometriosis.
Wang D; Guo C; Li Y; Zhou M; Wang H; Liu J; Chen P
Reprod Biomed Online; 2022 Jan; 44(1):27-37. PubMed ID: 34799276
[TBL] [Abstract][Full Text] [Related]
6. Possible relevance of tumor-related genes mutation to malignant transformation of endometriosis.
Ma X; Hui Y; Lin L; Wu Y; Zhang X; Qin X
Eur J Gynaecol Oncol; 2016; 37(1):89-94. PubMed ID: 27048117
[TBL] [Abstract][Full Text] [Related]
7. The High Expression of RRM2 Can Predict the Malignant Transformation of Endometriosis.
Yang B; Wang T; Li N; Zhang W; Hu Y
Adv Ther; 2021 Oct; 38(10):5178-5190. PubMed ID: 34424503
[TBL] [Abstract][Full Text] [Related]
8. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of genome-wide gene expression and DNA methylation profiles reveals candidate genes in ovary endometriosis.
Lei L; Xu X; Gong C; Lin B; Li F
Front Endocrinol (Lausanne); 2023; 14():1093683. PubMed ID: 37033258
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma.
Guo W; Dong Z; Guo Y; Shen S; Guo X; Kuang G; Yang Z
Mol Carcinog; 2016 Nov; 55(11):1655-1666. PubMed ID: 26456015
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation profile of ovarian epithelial neoplasms.
Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
[TBL] [Abstract][Full Text] [Related]
12. Discovering the Deregulated Molecular Functions Involved in Malignant Transformation of Endometriosis to Endometriosis-Associated Ovarian Carcinoma Using a Data-Driven, Function-Based Analysis.
Chang CM; Yang YP; Chuang JH; Chuang CM; Lin TW; Wang PH; Yu MH; Chang CC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113136
[TBL] [Abstract][Full Text] [Related]
13. Aberrant promoter methylation of the RASSF1A and APC genes in epithelial ovarian carcinoma development.
Bhagat R; Chadaga S; Premalata CS; Ramesh G; Ramesh C; Pallavi VR; Krishnamoorthy L
Cell Oncol (Dordr); 2012 Dec; 35(6):473-9. PubMed ID: 23055343
[TBL] [Abstract][Full Text] [Related]
14. MiR-191 modulates malignant transformation of endometriosis through regulating TIMP3.
Dong M; Yang P; Hua F
Med Sci Monit; 2015 Mar; 21():915-20. PubMed ID: 25819812
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer.
Cooper WN; Dickinson RE; Dallol A; Grigorieva EV; Pavlova TV; Hesson LB; Bieche I; Broggini M; Maher ER; Zabarovsky ER; Clark GJ; Latif F
Oncogene; 2008 Mar; 27(12):1805-11. PubMed ID: 17891178
[TBL] [Abstract][Full Text] [Related]
16. [Methylation and protein expression of RASSF2 in prostate cancer].
Liu G; Yin B; Song YS
Zhonghua Nan Ke Xue; 2013 Feb; 19(2):107-10. PubMed ID: 23441448
[TBL] [Abstract][Full Text] [Related]
17. RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer.
Häfner N; Steinbach D; Jansen L; Diebolder H; Dürst M; Runnebaum IB
Int J Cancer; 2016 Jan; 138(1):217-28. PubMed ID: 26175272
[TBL] [Abstract][Full Text] [Related]
18. Relationship between methylation status of RASSF2A gene promoter and endometriosis-associated ovarian cancer.
Xia Y; Xiong N; Huang Y
J Biol Regul Homeost Agents; 2018; 32(1):21-28. PubMed ID: 29504361
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of RASSF2A in tumors and plasma of patients with epithelial ovarian cancer.
Wu Y; Zhang X; Lin L; Ma XP; Ma YC; Liu PS
Asian Pac J Cancer Prev; 2014; 15(3):1171-6. PubMed ID: 24606436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
